1. Home /
  2. Biotechnology

Biotechnology

Gilead Sciences Teams With Novo Nordisk for Trials of Liver Disease Drugs

Gilead Sciences Teams With Novo Nordisk for Trials of Liver Disease Drugs

Gilead Sciences is partnering with Novo Nordisk to help combat liver disease.

Wave Life Sciences Plunges on Clinical Trial Data Delay

Wave Life Sciences Plunges on Clinical Trial Data Delay

Wave Life Sciences now says its Huntington's disease treatment data won't be available until the end of the year.

Netflix vs. Disney: Whose Streaming Service Should You Bet On?

Netflix vs. Disney: Whose Streaming Service Should You Bet On?

The battle for subscribers and content among streaming video providers is only going to get more intense in 2019. Here is why Disney is the superior investment over Netflix.

You Don't Have to Swing for the Fences With Every Investment in Small Caps

You Don't Have to Swing for the Fences With Every Investment in Small Caps

The way I do that is by using buy-write option strategies.

In the Age of Algorithms

In the Age of Algorithms

A close near the lows of the day will be a significant shift in the market action.

Zogenix Shares Plummet After FDA Rejection of Seizure Treatment

Zogenix Shares Plummet After FDA Rejection of Seizure Treatment

Shares of Zogenix plunge after the FDA rejects an initial marketing application for one of its more promising epilepsy treatment drugs.

Roche Buys More Time in $4.3B Offer for Spark Therapeutics

Roche Buys More Time in $4.3B Offer for Spark Therapeutics

Roche plans to regroup on its $4.3 billion offer to buy Spark Therapeutics after failing to win enough Spark shareholder votes, or receiving U.S. regulatory approval.

3 Promising Small Biotech Stocks to Watch

3 Promising Small Biotech Stocks to Watch

I think there is still upside left in a variety of smaller names especially if M&A activity picks up across the industry.

Sangamo Stock Soars on Positive Hemophilia Treatment Trial

Sangamo Stock Soars on Positive Hemophilia Treatment Trial

The stock surges on 'encouraging' results from a genome-therapy trial for the treatment of a severe type of hemophilia.

Keep Your Eye on the Oncology Sector Among Biotech Stocks

Keep Your Eye on the Oncology Sector Among Biotech Stocks

The myriad names in oncology have been the hottest area for acquisitions along with gene therapy.